Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne Barlier

Showing results (121-130 of 166) with videos related to

Pageof 17
Sort By:
Langenbeck'S Archives of Surgery|February 24, 2017
Implications of SDHB genetic testing in patients with sporadic pheochromocytomaAurelie Maignan, Carole Guerin, Valentin Julliard, et al.
Epigenetics|August 17, 2012
A genome-wide approach reveals novel imprinted genes expressed in the human placentaSandrine Barbaux, Géraldine Gascoin-Lachambre, Christophe Buffat, et al.
Frontiers in Endocrinology|September 15, 2023
The clinical and therapeutic profiles of prolactinomas associated with germline pathogenic variants in the <i>aryl hydrocarbon receptor interacting protein</i> (AIP) geneLaurent Vroonen, Albert Beckers, Severine Camby, et al.
Endocrine-Related Cancer|July 12, 2014
Pasireotide and octreotide antiproliferative effects and sst2 trafficking in human pancreatic neuroendocrine tumor culturesAmira Mohamed, Marie-Pierre Blanchard, Manuela Albertelli, et al.
Neoplasia (New York, N.Y.)|January 28, 2015
Metabolome profiling by HRMAS NMR spectroscopy of pheochromocytomas and paragangliomas detects SDH deficiency: clinical and pathophysiological implicationsAlessio Imperiale, François-Marie Moussallieh, Philippe Roche, et al.
Acta Neuropathologica|November 17, 2010
Absence of IDH mutation identifies a novel radiologic and molecular subtype of WHO grade II gliomas with dismal prognosisPhilippe Metellus, Bema Coulibaly, Carole Colin, et al.
Endocrine-Related Cancer|January 18, 2019
Metabolomics signatures of a subset of RET variants according to their oncogenic risk levelCharlotte Veyrat-Durebex, Nathalie Bouzamondo, Morgane Le Mao, et al.
Journal of Medical Genetics|November 18, 2023
Update of the UMD-VHL database: classification of 164 challenging variants based on genotype-phenotype correlation among 605 entriesGregory Mougel, Amira Mohamed, Nelly Burnichon, et al.
Endocrine-Related Cancer|September 25, 2015
Copy number variations alter methylation and parallel IGF2 overexpression in adrenal tumorsHelene Myrtue Nielsen, Alexandre How-Kit, Carole Guerin, et al.
The Journal of Clinical Endocrinology and Metabolism|January 8, 2013
Frequent large germline HRPT2 deletions in a French National cohort of patients with primary hyperparathyroidismLéopoldine Bricaire, Marie-Françoise Odou, Catherine Cardot-Bauters, et al.
Pageof 17

Showing results (121-130 of 166) with videos related to

Sort By:
Pageof 17
Langenbeck'S Archives of Surgery|February 24, 2017
Implications of SDHB genetic testing in patients with sporadic pheochromocytomaAurelie Maignan, Carole Guerin, Valentin Julliard, et al.
Epigenetics|August 17, 2012
A genome-wide approach reveals novel imprinted genes expressed in the human placentaSandrine Barbaux, Géraldine Gascoin-Lachambre, Christophe Buffat, et al.
Frontiers in Endocrinology|September 15, 2023
The clinical and therapeutic profiles of prolactinomas associated with germline pathogenic variants in the <i>aryl hydrocarbon receptor interacting protein</i> (AIP) geneLaurent Vroonen, Albert Beckers, Severine Camby, et al.
Endocrine-Related Cancer|July 12, 2014
Pasireotide and octreotide antiproliferative effects and sst2 trafficking in human pancreatic neuroendocrine tumor culturesAmira Mohamed, Marie-Pierre Blanchard, Manuela Albertelli, et al.
Neoplasia (New York, N.Y.)|January 28, 2015
Metabolome profiling by HRMAS NMR spectroscopy of pheochromocytomas and paragangliomas detects SDH deficiency: clinical and pathophysiological implicationsAlessio Imperiale, François-Marie Moussallieh, Philippe Roche, et al.
Acta Neuropathologica|November 17, 2010
Absence of IDH mutation identifies a novel radiologic and molecular subtype of WHO grade II gliomas with dismal prognosisPhilippe Metellus, Bema Coulibaly, Carole Colin, et al.
Endocrine-Related Cancer|January 18, 2019
Metabolomics signatures of a subset of RET variants according to their oncogenic risk levelCharlotte Veyrat-Durebex, Nathalie Bouzamondo, Morgane Le Mao, et al.
Journal of Medical Genetics|November 18, 2023
Update of the UMD-VHL database: classification of 164 challenging variants based on genotype-phenotype correlation among 605 entriesGregory Mougel, Amira Mohamed, Nelly Burnichon, et al.
Endocrine-Related Cancer|September 25, 2015
Copy number variations alter methylation and parallel IGF2 overexpression in adrenal tumorsHelene Myrtue Nielsen, Alexandre How-Kit, Carole Guerin, et al.
The Journal of Clinical Endocrinology and Metabolism|January 8, 2013
Frequent large germline HRPT2 deletions in a French National cohort of patients with primary hyperparathyroidismLéopoldine Bricaire, Marie-Françoise Odou, Catherine Cardot-Bauters, et al.
Pageof 17